AU2001267181A1 - Polyubiquitin based hydrogel and uses thereof - Google Patents

Polyubiquitin based hydrogel and uses thereof

Info

Publication number
AU2001267181A1
AU2001267181A1 AU2001267181A AU6718101A AU2001267181A1 AU 2001267181 A1 AU2001267181 A1 AU 2001267181A1 AU 2001267181 A AU2001267181 A AU 2001267181A AU 6718101 A AU6718101 A AU 6718101A AU 2001267181 A1 AU2001267181 A1 AU 2001267181A1
Authority
AU
Australia
Prior art keywords
polyubiquitin
based hydrogel
hydrogel
polyubiquitin based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267181A
Other languages
English (en)
Inventor
Marc Bosse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viridis Biotech Inc
Original Assignee
Viridis Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viridis Biotech Inc filed Critical Viridis Biotech Inc
Publication of AU2001267181A1 publication Critical patent/AU2001267181A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001267181A 2000-05-30 2001-05-29 Polyubiquitin based hydrogel and uses thereof Abandoned AU2001267181A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20732500P 2000-05-30 2000-05-30
US60/207,325 2000-05-30
PCT/CA2001/000784 WO2001091814A2 (en) 2000-05-30 2001-05-29 Polyubiquitin based hydrogel and uses thereof

Publications (1)

Publication Number Publication Date
AU2001267181A1 true AU2001267181A1 (en) 2001-12-11

Family

ID=22770059

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267181A Abandoned AU2001267181A1 (en) 2000-05-30 2001-05-29 Polyubiquitin based hydrogel and uses thereof

Country Status (6)

Country Link
US (1) US6881789B2 (de)
EP (1) EP1284992A2 (de)
JP (1) JP2003535165A (de)
AU (1) AU2001267181A1 (de)
CA (1) CA2409188A1 (de)
WO (1) WO2001091814A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842420B1 (fr) * 2002-07-16 2006-07-14 Rocher Yves Biolog Vegetale Composition cosmetique comprenant de l'ubiquitine
US7872804B2 (en) 2002-08-20 2011-01-18 Illumina, Inc. Encoded particle having a grating with variations in the refractive index
US7619819B2 (en) 2002-08-20 2009-11-17 Illumina, Inc. Method and apparatus for drug product tracking using encoded optical identification elements
US7508608B2 (en) 2004-11-17 2009-03-24 Illumina, Inc. Lithographically fabricated holographic optical identification element
US7923260B2 (en) 2002-08-20 2011-04-12 Illumina, Inc. Method of reading encoded particles
US7164533B2 (en) 2003-01-22 2007-01-16 Cyvera Corporation Hybrid random bead/chip based microarray
US7900836B2 (en) 2002-08-20 2011-03-08 Illumina, Inc. Optical reader system for substrates having an optically readable code
US7901630B2 (en) 2002-08-20 2011-03-08 Illumina, Inc. Diffraction grating-based encoded microparticle assay stick
JP5156890B2 (ja) * 2002-09-11 2013-03-06 独立行政法人物質・材料研究機構 高分子架橋体及びその製造方法
US7092160B2 (en) 2002-09-12 2006-08-15 Illumina, Inc. Method of manufacturing of diffraction grating-based optical identification element
US20100255603A9 (en) * 2002-09-12 2010-10-07 Putnam Martin A Method and apparatus for aligning microbeads in order to interrogate the same
CA2498933C (en) * 2002-09-12 2012-08-28 Cyvera Corporation Method and apparatus for aligning elongated microbeads in order to interrogate the same
WO2004104021A2 (en) * 2003-05-14 2004-12-02 Dow Corning Corporation Controlled release of active agents utilizing repeat sequence protein polymers
CA2576040A1 (en) * 2003-10-21 2005-04-28 Bioartificial Gel Technologies Inc. Hydrogel-containing medical articles and methods of using and making the same
US7433123B2 (en) * 2004-02-19 2008-10-07 Illumina, Inc. Optical identification element having non-waveguide photosensitive substrate with diffraction grating therein
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
WO2006055735A2 (en) * 2004-11-16 2006-05-26 Illumina, Inc Scanner having spatial light modulator
CN101116086A (zh) 2004-11-16 2008-01-30 伊路敏纳公司 读取编码微珠的方法和设备
US7830575B2 (en) 2006-04-10 2010-11-09 Illumina, Inc. Optical scanner with improved scan time
CN100384923C (zh) * 2006-04-28 2008-04-30 江南大学 一种透明质酸-壳聚糖交联生物相容材料的制备方法
US20090038066A1 (en) * 2007-04-04 2009-02-12 Global Sanitation Solutions, Inc. Systems and methods for providing a portable toilet system
US20100275362A1 (en) * 2007-04-04 2010-11-04 Stephen Biesinger Systems and methods for providing a portable toilet system
AR074874A1 (es) 2008-12-23 2011-02-16 Biosource Pharm Inc Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
MX2012007056A (es) 2009-12-16 2012-09-28 Baxter Healthcare Sa Esponja hemostatica.
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CN105297440B (zh) * 2015-11-11 2018-01-12 浙江理工大学 一种对蚕丝接枝改性的方法
TWI644676B (zh) * 2017-08-28 2018-12-21 婁敬 Antibacterial hydrogel
BR112022010445A2 (pt) * 2019-11-27 2022-09-06 Onegene Biotechnology Inc Polímero biomolecular multifuncional, multiespecífico, multimérico , método para preparar um polímero biomolecular multifuncional, multiespecífico, multimérico
CN111249532A (zh) * 2020-01-16 2020-06-09 广东省人民医院(广东省医学科学院) 一种用于软骨修复的可注射透明质酸水凝胶及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47468A (en) 1975-06-12 1979-05-31 Rehovot Res Prod Process for the cross-linking of proteins using water soluble cross-linking agents
JPH0830004B2 (ja) * 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
CA1223222A (en) 1984-02-22 1987-06-23 Nanibhushan Dattagupta Immobilized nucleic acid-containing probes
US5108919A (en) * 1988-06-24 1992-04-28 Genentech, Inc. Dna sequences encoding yeast ubiquitin hydrolase
DK0400472T3 (da) * 1989-05-27 1996-05-13 Sumitomo Pharma Fremgangsmåde til fremstilling af polyethylenglycolderivater og modificeret protein
AU1060495A (en) 1993-12-01 1995-06-19 Universite Du Quebec A Montreal Albumin based hydrogel
US5891558A (en) 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5709934A (en) * 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
US6039940A (en) * 1996-10-28 2000-03-21 Ballard Medical Products Inherently antimicrobial quaternary amine hydrogel wound dressings
US6319503B1 (en) * 1998-02-19 2001-11-20 Proteinix Company Heat shock fusion-based vaccine system

Also Published As

Publication number Publication date
US20030114724A1 (en) 2003-06-19
EP1284992A2 (de) 2003-02-26
WO2001091814A3 (en) 2002-08-08
WO2001091814A2 (en) 2001-12-06
CA2409188A1 (en) 2001-12-06
US6881789B2 (en) 2005-04-19
JP2003535165A (ja) 2003-11-25

Similar Documents

Publication Publication Date Title
AU2001267181A1 (en) Polyubiquitin based hydrogel and uses thereof
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
AU2001227916A1 (en) Earplug
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2001273569A1 (en) Perfluoropolyethers and processes therefor and therewith
AU2001288694A1 (en) Nitric oxide-producing hydrogel materials
AU2001282882A1 (en) Roll-formed and stamped doorbeam
AU2002213355A1 (en) Wireless asp systems and methods
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001257124A1 (en) Wireless portfolio system and device
AU2001291132A1 (en) Lymphoma associated molecules and uses therefor
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AUPR218000A0 (en) Polymer gels and their preparation
AU2002306887A1 (en) Graphics-protection sheet and graphics-displaying sheet
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2002256556A1 (en) Sea-trosy and related methods
AU5979300A (en) Angiopoietin-6 and uses thereof
AU2669201A (en) Taccalonolides and their use
AU2002227019A1 (en) Cashcalling and voicemining system
AU2001251370A1 (en) Antimicrobial methods and materials